ELAVL1 and metabolic dysfunction-associated steatotic liver disease: Further investigation is needed to elucidate HuR’s mechanistic involvement in apoptosis, necroptosis, pyroptosis, and ferroptosis during MASLD development and progression, and to evaluate its potential as a therapeutic target in MASLD.